Related Experiment Video
Updated: Aug 9, 2026

09:27
Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
Published on: April 2, 2021
Modulation of amphotericin B activity by association with mannose ester
H Rocheleau1, G Saint-Germain, J Barwicz
1Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Canada.
Immunopharmacology and Immunotoxicology
|August 1, 1994
Summary
A new Amphotericin B (AmB) formulation with palmitoyl mannose reduces toxicity and enhances antifungal activity. This complex formation may improve therapeutic efficiency and immunoadjuvant properties for fungal infections.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Amphotericin B (AmB) is a potent antifungal agent with significant toxicity.
- Developing safer and more effective AmB formulations is crucial for treating invasive fungal infections.
Purpose of the Study:
- To investigate the biological and molecular properties of a novel Amphotericin B formulation complexed with palmitoyl mannose.
- To assess the impact of palmitoyl mannose on AmB's toxicity, efficacy, and inflammatory potential.
Main Methods:
- In vitro and in vivo studies were conducted.
- Evaluated cytotoxicity against mammalian cells and fungi.
- Assessed effects on macrophage activity, inflammatory properties, and acute toxicity in mice.
- Analyzed spectral behavior in the presence of serum or propanol.
Main Results:
- The AmB-palmitoyl mannose complex showed decreased cytotoxicity to both fungal and mammalian cells.
- Fungistatic potential of AmB was increased in the complex.
- Inflammatory properties were conserved, and acute toxicity in mice was significantly diminished.
- Complex formation likely impedes AmB interaction with serum or cell membranes.
Conclusions:
- The new AmB formulation demonstrates a potentially improved therapeutic profile with reduced toxicity.
- The complex may enhance immunoadjuvant properties and localize inflammation, leading to better treatment outcomes.
- This formulation offers a promising strategy for safer and more effective antifungal therapy.
Related Concept Videos
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

